Why Achillion Has Plunged 30%
November 03, 2016 at 12:29 PM EDT
Shares of Achillion Pharmaceuticals ( ACHN ) are in freefall today after the biotech company reported some problems with an early-stage drug trial of a blood-disease treatment . Jefferies analyst Brian Abrahams and team explain:
